Radek Frič
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Radek Frič has a total of 122 co-authors. Here are the top co-authors by number of shared publications:
Per Kristian Eide
Departments of Neurosurgery and
10 shared publicationsBernt Johan Due-Tønnessen
Department of Neurosurgery, Oslo University Hospital-Rikshospitalet, P.O.Box 4950, N-0424, Oslo, Norway
7 shared publicationsArild Egge
Dept. of Neurosurgery, Oslo University Hospital-Rikshospitalet, N-0424, Oslo, Norway
4 shared publications- Marianne Juhler
Department of Neurosurgery, Rigshospitalet, Copenhagen, Denmark
4 shared publications - Aske Foldbjerg Laustsen
Department of Neurosurgery, Rigshospitalet, Copenhagen, Denmark
3 shared publications Bernt J. Due-Tønnessen
Department of Neurosurgery, Oslo University Hospital, Oslo, Norway
3 shared publications
Latest Publications
- Open Access
- 26 May 2026
- Published by Springer Nature in Child's Nervous System
- Vol. 42 (1)
Epidermoid cysts of the cerebellopontine angle in pediatric population—an institutional surgical case series and review of literature
Epidermoid cysts (EC) are rare intracranial lesions, particularly uncommon in children, arising from ectodermal inclusions during neural tube closure. Although they are often located in the cerebellopontine angle (CPA), data on complication and recurrence rates after surgery for EC in this location in children remain limited. We retrospectively reviewed data from children (≤ 18 years) surgically treated for EC in CPA at the Oslo University Hospital-Rikshospitalet between 2004 and 2024, with > 1 year of follow-up. Clinical presentation, imaging, and surgical outcomes were assessed. A systematic review of the literature was conducted according to PRISMA guidelines. Six patients (mean age 15 ± 2 years, range 12-17; male/female ratio 1:2) were included. The most common presenting symptoms were headache (83%) and ataxia (33%). Mean diameter on preoperative MRI was 37 ± 5.4 mm (range 30-45). All patients were treated using the standard retrosigmoid approach. Gross total resection (GTR) was achieved in four patients (67%). Postoperative complications were limited to transient diplopia and hearing impairment, respectively, in two patients (34%). No mortality or permanent morbidity was observed. Recurrence was observed in two patients, in one of them after GTR. EC of the CPA in children can be safely and effectively removed, yielding favorable outcomes with low morbidity. Although GTR should be attempted, residual tissue may persist in hidden anatomical recesses and predispose to recurrence after subtotal removal. Endoscopic assistance may enhance the completeness of resection. Small asymptomatic remnants can be monitored. Long-term MRI follow-up is recommended.
- 26 May 2026
- Published by Springer Nature in Child's Nervous System
- Vol. 42 (1)
Open AccessEpidermoid cysts of the cerebellopontine angle in pediatric population—an institutional surgical case series and review of literature
Epidermoid cysts (EC) are rare intracranial lesions, particularly uncommon in children, arising from ectodermal inclusions during neural tube closure. Although they are often located in the cerebellopontine angle (CPA), data on complication and recurrence rates after surgery for EC in this location in children remain limited. We retrospectively reviewed data from children (≤ 18 years) surgically treated for EC in CPA at the Oslo University Hospital-Rikshospitalet between 2004 and 2024, with > 1 year of follow-up. Clinical presentation, imaging, and surgical outcomes were assessed. A systematic review of the literature was conducted according to PRISMA guidelines. Six patients (mean age 15 ± 2 years, range 12-17; male/female ratio 1:2) were included. The most common presenting symptoms were headache (83%) and ataxia (33%). Mean diameter on preoperative MRI was 37 ± 5.4 mm (range 30-45). All patients were treated using the standard retrosigmoid approach. Gross total resection (GTR) was achieved in four patients (67%). Postoperative complications were limited to transient diplopia and hearing impairment, respectively, in two patients (34%). No mortality or permanent morbidity was observed. Recurrence was observed in two patients, in one of them after GTR. EC of the CPA in children can be safely and effectively removed, yielding favorable outcomes with low morbidity. Although GTR should be attempted, residual tissue may persist in hidden anatomical recesses and predispose to recurrence after subtotal removal. Endoscopic assistance may enhance the completeness of resection. Small asymptomatic remnants can be monitored. Long-term MRI follow-up is recommended.
- Open Access
- 4 February 2026
- Published by Springer Nature in Child's Nervous System
- Vol. 42 (1) , 59
Nordic survey on practice of neurosurgical management of craniopharyngioma in children
Purpose: Management of childhood-onset craniopharyngioma (CP) may be challenging, given its rarity and complexity as well as the risks associated with treatment. We aimed at investigating how the practice of neurosurgical management of CP in children differs among neurosurgical centres in Nordic countries. Methods: We performed a survey containing 28 questions and focusing on organization of care, expertise availability, treatment decisions and strategies, and follow-up routines, respectively. The survey was distributed to 21 neurosurgical centres in five Nordic countries. Results: We obtained answers from 18 centres (86% response rate). In 61% of centres, only 0–1 new cases are treated per year. In only one country (Denmark), the neurosurgical treatment of pediatric CP is centralized to one centre. While all cases are discussed at MDT meetings before surgery and during the follow-up, management strategies, including surgical indications, goals, and approaches, vary substantially among responding centres. Conclusion: The practice of neurosurgical management of pediatric CP in the Nordic countries is characterized by relatively low case volumes, differing management strategies, as well as varying degrees of centralization and collaboration between pediatric and adult neurosurgeons. Although some practical aspects may be unique for healthcare practised in the Nordic countries, the results of this survey and, in particular, the embedded discussion of centralization – either restricted to surgery or including complete management of pediatric CP – seem relevant and may provide useful insights also to neurosurgeons outside of the Nordics.
- 4 February 2026
- Published by Springer Nature in Child's Nervous System
- Vol. 42 (1) , 59
Open AccessNordic survey on practice of neurosurgical management of craniopharyngioma in children
Purpose: Management of childhood-onset craniopharyngioma (CP) may be challenging, given its rarity and complexity as well as the risks associated with treatment. We aimed at investigating how the practice of neurosurgical management of CP in children differs among neurosurgical centres in Nordic countries. Methods: We performed a survey containing 28 questions and focusing on organization of care, expertise availability, treatment decisions and strategies, and follow-up routines, respectively. The survey was distributed to 21 neurosurgical centres in five Nordic countries. Results: We obtained answers from 18 centres (86% response rate). In 61% of centres, only 0–1 new cases are treated per year. In only one country (Denmark), the neurosurgical treatment of pediatric CP is centralized to one centre. While all cases are discussed at MDT meetings before surgery and during the follow-up, management strategies, including surgical indications, goals, and approaches, vary substantially among responding centres. Conclusion: The practice of neurosurgical management of pediatric CP in the Nordic countries is characterized by relatively low case volumes, differing management strategies, as well as varying degrees of centralization and collaboration between pediatric and adult neurosurgeons. Although some practical aspects may be unique for healthcare practised in the Nordic countries, the results of this survey and, in particular, the embedded discussion of centralization – either restricted to surgery or including complete management of pediatric CP – seem relevant and may provide useful insights also to neurosurgeons outside of the Nordics.
- Open Access
- 19 January 2026
- Published by Elsevier in Brain and Spine
- Vol. 6
Organizational management of moderate and severe paediatric traumatic brain injury: results from a European survey
- 19 January 2026
- Published by Elsevier in Brain and Spine
- Vol. 6
Open AccessOrganizational management of moderate and severe paediatric traumatic brain injury: results from a European survey
- Open Access
- 22 September 2025
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 167 (1) , 1-11
Postoperative speech impairment and cranial nerve deficits in children undergoing posterior fossa tumor surgery with intraoperative MRI – a prospective multinational study
Background: Postoperative speech impairment (POSI) and cranial nerve deficits (CND) are common complications of pediatric posterior fossa (PF) tumor surgery. Intraoperative MRI (ioMRI) has proven a useful tool in achieving gross total resection. The risk of POSI and CND with ioMRI remains unclear, making it the primary scope of this study. Additionally, we assessed whether POSI was associated with CND. Methods: We prospectively included pediatric patients undergoing PF tumor surgery in 36 centers across 15 European countries. Neurological status and speech were assessed preoperatively and 1–4 weeks postoperatively. Surgical details, including tumor location and use of ioMRI, were recorded within 72 h of surgery. Postoperative CND were categorized as 0, 1, 2, or ≥ 3 nerves affected; POSI as habitual, reduced speech, or mutism. Proportional odds models estimated odds ratios (OR) for 1) POSI with stepwise adjustment for tumor location and age, and 2) CND with adjustment for preoperative CND and tumor location. Subgroup analyses assessed systematic differences, missing data, center-level effects, and histology adjustment. Results: Of 790 primary PF tumor surgeries, 141 (18%) involved ioMRI. POSI occurred in 183/790 (23%) and postoperative CND in 213/790 (27%). POSI-risk with ioMRI showed non-significant unadjusted OR (95% CI) 0.83 (0.53;1.30); adjusted OR 0.76 (0.43;1.35). Fewer CNDs were observed with ioMRI (unadjusted OR 0.63 (0.40;1.00), adjusted OR 0.58 (0.33;0.94), p = 0.03). POSI-risk was associated with more CNDs (adjusted OR for 1 CND: 2.06 (1.15;3.68); 2 CND: 2.13 (1.02;4.42); ≥ 3 CND: 4.15 (1.98;8.70), p < 0.05). Conclusions: ioMRI was not associated with increased risk of postoperative complications in this multicenter cohort. The reduction in CND among ioMRI cases may reflect derived effects on surgical decision-making, expertise, case-load and case-mix. Results should be interpreted with caution due to limited intraoperative data. The association between POSI-risk and cumulative CND may indicate extensive brainstem involvement. Our findings highlight the need to further explore how ioMRI-guided strategies affect functional outcomes in pediatric PF tumour surgery. Clinical Trials ID: NCT02300766 (October 2014)
- 22 September 2025
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 167 (1) , 1-11
Open AccessPostoperative speech impairment and cranial nerve deficits in children undergoing posterior fossa tumor surgery with intraoperative MRI – a prospective multinational study
Background: Postoperative speech impairment (POSI) and cranial nerve deficits (CND) are common complications of pediatric posterior fossa (PF) tumor surgery. Intraoperative MRI (ioMRI) has proven a useful tool in achieving gross total resection. The risk of POSI and CND with ioMRI remains unclear, making it the primary scope of this study. Additionally, we assessed whether POSI was associated with CND. Methods: We prospectively included pediatric patients undergoing PF tumor surgery in 36 centers across 15 European countries. Neurological status and speech were assessed preoperatively and 1–4 weeks postoperatively. Surgical details, including tumor location and use of ioMRI, were recorded within 72 h of surgery. Postoperative CND were categorized as 0, 1, 2, or ≥ 3 nerves affected; POSI as habitual, reduced speech, or mutism. Proportional odds models estimated odds ratios (OR) for 1) POSI with stepwise adjustment for tumor location and age, and 2) CND with adjustment for preoperative CND and tumor location. Subgroup analyses assessed systematic differences, missing data, center-level effects, and histology adjustment. Results: Of 790 primary PF tumor surgeries, 141 (18%) involved ioMRI. POSI occurred in 183/790 (23%) and postoperative CND in 213/790 (27%). POSI-risk with ioMRI showed non-significant unadjusted OR (95% CI) 0.83 (0.53;1.30); adjusted OR 0.76 (0.43;1.35). Fewer CNDs were observed with ioMRI (unadjusted OR 0.63 (0.40;1.00), adjusted OR 0.58 (0.33;0.94), p = 0.03). POSI-risk was associated with more CNDs (adjusted OR for 1 CND: 2.06 (1.15;3.68); 2 CND: 2.13 (1.02;4.42); ≥ 3 CND: 4.15 (1.98;8.70), p < 0.05). Conclusions: ioMRI was not associated with increased risk of postoperative complications in this multicenter cohort. The reduction in CND among ioMRI cases may reflect derived effects on surgical decision-making, expertise, case-load and case-mix. Results should be interpreted with caution due to limited intraoperative data. The association between POSI-risk and cumulative CND may indicate extensive brainstem involvement. Our findings highlight the need to further explore how ioMRI-guided strategies affect functional outcomes in pediatric PF tumour surgery. Clinical Trials ID: NCT02300766 (October 2014)
- 4 September 2025
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 145 (10)
Lukking av bløtvevsdefekter ved kirurgi for åpent ryggmargsbrokk
04.09.2025: Kort rapport - 7 av 18 nyfødte operert for åpent ryggmargsbrokk fikk postoperative komplikasjoner, og fire måtte reopereres.
- 4 September 2025
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 145 (10)
Lukking av bløtvevsdefekter ved kirurgi for åpent ryggmargsbrokk
04.09.2025: Kort rapport - 7 av 18 nyfødte operert for åpent ryggmargsbrokk fikk postoperative komplikasjoner, og fire måtte reopereres.
- Open Access
- 11 July 2025
- Published by Springer Nature in Child's Nervous System
- Vol. 41 (1) , 1-11
Glucocorticoid use in paediatric posterior fossa tumour surgery and the occurrence of postoperative speech impairment
Purpose: Postoperative speech impairment (POSI) is a core symptom of cerebellar mutism syndrome (CMS) and is a common complication after the resection of paediatric posterior fossa (PF) tumours. Preoperative glucocorticoids (pGC) are considered standard treatment to reduce tumour oedema; in addition, glucocorticoids are often administered intraoperatively (iGC) to reduce both postoperative nausea and vomiting. The study aims to investigate whether the occurrence of POSI may be associated with pGC and iGC. Methods: In a prospective observational multicentre study, we included children with a PF tumour requiring either resection or open biopsy. The use of pGC and iGC, including drug type and dose, was registered. Postoperative speech status was classified as mutism, reduced speech, or habitual speech, where mutism and reduced speech were considered POSI of higher and lower severity, respectively. Proportional odds logistic regression with adjustment for tumour type, tumour location, and age was used to analyse the occurrence of POSI associated with glucocorticoids (GC). Results: From August 2014 to November 2024, we recruited 810 children, of whom 605 were included in the primary analysis. We found no association between the use of GC (pGC nor iGC) and the occurrence of POSI. The result did not change when adjusting for tumour type, tumour location, and age. The analysis included both a comparison between using and not using pGC (OR 1.06 [95% CI 0.46 –2.49], reference level: use of pGC) and/or iGC (1.28 [0.58–2.82], reference level: use of iGC), and a dose–response analysis of the occurrence of POSI in relation to doubling the dose of GC (pGC OR 1.28 [0.84–1.98]; iGC OR 1.07 [0.62–1.82]). Conclusion: Our study did not find evidence of a significant change in the occurrence of POSI with the use of pGC or iGC, but our results alone cannot rule out that the administration of pGC or iGC may have some effect. Therefore, our data do not call for a change in recommendations for the use of GC as protection against the development of POSI. Trial registration number: Clinicaltrials.gov (NCT02300766). Date of registration: November 25, 2014
- 11 July 2025
- Published by Springer Nature in Child's Nervous System
- Vol. 41 (1) , 1-11
Open AccessGlucocorticoid use in paediatric posterior fossa tumour surgery and the occurrence of postoperative speech impairment
Purpose: Postoperative speech impairment (POSI) is a core symptom of cerebellar mutism syndrome (CMS) and is a common complication after the resection of paediatric posterior fossa (PF) tumours. Preoperative glucocorticoids (pGC) are considered standard treatment to reduce tumour oedema; in addition, glucocorticoids are often administered intraoperatively (iGC) to reduce both postoperative nausea and vomiting. The study aims to investigate whether the occurrence of POSI may be associated with pGC and iGC. Methods: In a prospective observational multicentre study, we included children with a PF tumour requiring either resection or open biopsy. The use of pGC and iGC, including drug type and dose, was registered. Postoperative speech status was classified as mutism, reduced speech, or habitual speech, where mutism and reduced speech were considered POSI of higher and lower severity, respectively. Proportional odds logistic regression with adjustment for tumour type, tumour location, and age was used to analyse the occurrence of POSI associated with glucocorticoids (GC). Results: From August 2014 to November 2024, we recruited 810 children, of whom 605 were included in the primary analysis. We found no association between the use of GC (pGC nor iGC) and the occurrence of POSI. The result did not change when adjusting for tumour type, tumour location, and age. The analysis included both a comparison between using and not using pGC (OR 1.06 [95% CI 0.46 –2.49], reference level: use of pGC) and/or iGC (1.28 [0.58–2.82], reference level: use of iGC), and a dose–response analysis of the occurrence of POSI in relation to doubling the dose of GC (pGC OR 1.28 [0.84–1.98]; iGC OR 1.07 [0.62–1.82]). Conclusion: Our study did not find evidence of a significant change in the occurrence of POSI with the use of pGC or iGC, but our results alone cannot rule out that the administration of pGC or iGC may have some effect. Therefore, our data do not call for a change in recommendations for the use of GC as protection against the development of POSI. Trial registration number: Clinicaltrials.gov (NCT02300766). Date of registration: November 25, 2014
- Open Access
- 3 April 2025
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 167 (1) , 1-9
Tumour volume as a predictor of postoperative speech impairment in children undergoing resection of posterior fossa tumours: a prospective, multicentre study
Background: Cerebellar Mutism Syndrome (CMS) is a neurological complication of posterior fossa (PF) tumour surgery in children, and postoperative speech impairment (POSI) is the cardinal symptom of CMS. The role of tumour volume on the risk of POSI remains unexplored. This study investigates the association between tumour volume and the risk of POSI. Methods: We included 360 patients from the European CMS study with available preoperative T1-weighted contrast-enhanced brain MRI. Speech status was assessed within two weeks postoperatively and categorised into three levels: habitual speech, severely reduced speech, and mutism. Tumour volumes were calculated using the BrainLab Elements SmartBrush™, a semi-automated segmentation tool. We used proportional odds models to estimate the odds ratio (OR) with adjustments for tumour location, pathology, and age. Based on the primary analysis, a risk stratification model for medulloblastoma patients was constructed, and the optimal volume cut-off was determined with Youden’s Index. Results: We found no effect of the overall tumour volume on the risk of POSI. This result did not change when adjusted for tumour location, pathology, and age. We found an association between tumour volume of medulloblastoma and the risk of POSI (unadjusted OR of 1.04 per increase in cm3 (95% CI 1.01;1.07, p = 0.01)), which did not change when adjusting for tumour location and age. The risk stratification cut-off for the tumour volume of medulloblastoma was calculated to be 16,5 cm3. Patients with medulloblastoma and preoperative tumour volumes below 16,5 cm3 had an absolute risk of 13% for POSI (low-risk group), whereas patients with preoperative tumour volumes above 16,5 cm3 had an absolute risk of 50% for POSI (high-risk group). Conclusion: Our data showed an association between preoperative tumour volume and the risk of POSI in children with medulloblastoma, while no association was found for the volume of other tumour types. We suggest a straightforward cut-off risk model for assessing the risk of POSI in children with medulloblastoma based on preoperative tumour volume. This approach can aid clinicians in informing patients and parents about the complications related to CMS following PF tumour surgery in children. Clinical Trials: ID NCT02300766 (October 2014).
- 3 April 2025
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 167 (1) , 1-9
Open AccessTumour volume as a predictor of postoperative speech impairment in children undergoing resection of posterior fossa tumours: a prospective, multicentre study
Background: Cerebellar Mutism Syndrome (CMS) is a neurological complication of posterior fossa (PF) tumour surgery in children, and postoperative speech impairment (POSI) is the cardinal symptom of CMS. The role of tumour volume on the risk of POSI remains unexplored. This study investigates the association between tumour volume and the risk of POSI. Methods: We included 360 patients from the European CMS study with available preoperative T1-weighted contrast-enhanced brain MRI. Speech status was assessed within two weeks postoperatively and categorised into three levels: habitual speech, severely reduced speech, and mutism. Tumour volumes were calculated using the BrainLab Elements SmartBrush™, a semi-automated segmentation tool. We used proportional odds models to estimate the odds ratio (OR) with adjustments for tumour location, pathology, and age. Based on the primary analysis, a risk stratification model for medulloblastoma patients was constructed, and the optimal volume cut-off was determined with Youden’s Index. Results: We found no effect of the overall tumour volume on the risk of POSI. This result did not change when adjusted for tumour location, pathology, and age. We found an association between tumour volume of medulloblastoma and the risk of POSI (unadjusted OR of 1.04 per increase in cm3 (95% CI 1.01;1.07, p = 0.01)), which did not change when adjusting for tumour location and age. The risk stratification cut-off for the tumour volume of medulloblastoma was calculated to be 16,5 cm3. Patients with medulloblastoma and preoperative tumour volumes below 16,5 cm3 had an absolute risk of 13% for POSI (low-risk group), whereas patients with preoperative tumour volumes above 16,5 cm3 had an absolute risk of 50% for POSI (high-risk group). Conclusion: Our data showed an association between preoperative tumour volume and the risk of POSI in children with medulloblastoma, while no association was found for the volume of other tumour types. We suggest a straightforward cut-off risk model for assessing the risk of POSI in children with medulloblastoma based on preoperative tumour volume. This approach can aid clinicians in informing patients and parents about the complications related to CMS following PF tumour surgery in children. Clinical Trials: ID NCT02300766 (October 2014).
- 1 September 2024
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of neurosurgery. Pediatrics
- Vol. 34 (3) , 293-300
Intracranial pulse pressure amplitude as an indicator of intracranial compliance: observations in symptomatic children with Chiari malformation type I
OBJECTIVE: Reduced intracranial compliance (ICC) may be an important factor in the pathophysiology of Chiari malformation type I (CM-I). However, direct measurement of ICC is controversial because of its invasiveness, particularly in children. Instead, ICC may be estimated from continuous measurements of intracranial pressure (ICP), where the metric mean wave amplitude (MWA) has been found to be more useful as a surrogate marker of ICC than mean ICP. This observational study investigated the distribution of MWA and mean ICP in symptomatic children with CM-I, as well as their association with clinical and radiological findings. METHODS: From a consecutive series of children treated for CM-I at a single institution between 2006 and 2023, the authors analyzed ICP scores in those who underwent an overnight preoperative ICP recording in which MWA was calculated. Clinical and radiological data were retrieved from the patient records. RESULTS: Thirty-seven children (mean age 12.4 ± 3.6 years) with symptomatic CM-I were identified. From the overnight ICP measurements, the average MWA was 5.2 ± 1.3 mm Hg: 56% of children had an abnormal MWA (> 5 mm Hg) and 33% had a borderline MWA (4–5 mm Hg). In contrast, the average mean ICP was 9.7 ± 4.1 mm Hg: 8% of children had an abnormal mean ICP (> 15 mm Hg) and 41% had a borderline mean ICP (10–15 mm Hg). Thus, more children were found to have an abnormal MWA than an abnormal mean ICP (p < 0.001). MWA was significantly higher in the subgroup of children with medullary compression in the foramen magnum, as seen on MRI, than in those without (5.6 ± 1.0 mm Hg vs 4.7 ± 1.4 mm Hg, p = 0.03), whereas a similar difference was not observed for mean ICP (9.9 ± 4.6 mm Hg vs 9.7 ± 3.7 mm Hg, p = 0.889). CONCLUSIONS: In this cohort of symptomatic children with CM-I, MWA was more frequently abnormal than mean ICP, with a clinically significant discrepancy in half of the patients. Moreover, MWA was significantly higher in patients with medullary compression. Based on these findings, the authors’ interpretation is that in children with CM-I, the ICC may be reduced, as indicated by increased MWA, even though the mean ICP is within normal thresholds.
- 1 September 2024
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of neurosurgery. Pediatrics
- Vol. 34 (3) , 293-300
Intracranial pulse pressure amplitude as an indicator of intracranial compliance: observations in symptomatic children with Chiari malformation type I
OBJECTIVE: Reduced intracranial compliance (ICC) may be an important factor in the pathophysiology of Chiari malformation type I (CM-I). However, direct measurement of ICC is controversial because of its invasiveness, particularly in children. Instead, ICC may be estimated from continuous measurements of intracranial pressure (ICP), where the metric mean wave amplitude (MWA) has been found to be more useful as a surrogate marker of ICC than mean ICP. This observational study investigated the distribution of MWA and mean ICP in symptomatic children with CM-I, as well as their association with clinical and radiological findings. METHODS: From a consecutive series of children treated for CM-I at a single institution between 2006 and 2023, the authors analyzed ICP scores in those who underwent an overnight preoperative ICP recording in which MWA was calculated. Clinical and radiological data were retrieved from the patient records. RESULTS: Thirty-seven children (mean age 12.4 ± 3.6 years) with symptomatic CM-I were identified. From the overnight ICP measurements, the average MWA was 5.2 ± 1.3 mm Hg: 56% of children had an abnormal MWA (> 5 mm Hg) and 33% had a borderline MWA (4–5 mm Hg). In contrast, the average mean ICP was 9.7 ± 4.1 mm Hg: 8% of children had an abnormal mean ICP (> 15 mm Hg) and 41% had a borderline mean ICP (10–15 mm Hg). Thus, more children were found to have an abnormal MWA than an abnormal mean ICP (p < 0.001). MWA was significantly higher in the subgroup of children with medullary compression in the foramen magnum, as seen on MRI, than in those without (5.6 ± 1.0 mm Hg vs 4.7 ± 1.4 mm Hg, p = 0.03), whereas a similar difference was not observed for mean ICP (9.9 ± 4.6 mm Hg vs 9.7 ± 3.7 mm Hg, p = 0.889). CONCLUSIONS: In this cohort of symptomatic children with CM-I, MWA was more frequently abnormal than mean ICP, with a clinically significant discrepancy in half of the patients. Moreover, MWA was significantly higher in patients with medullary compression. Based on these findings, the authors’ interpretation is that in children with CM-I, the ICC may be reduced, as indicated by increased MWA, even though the mean ICP is within normal thresholds.
- Open Access
- 29 August 2024
- Published by Springer Nature in Child's Nervous System
- Vol. 40 (11) , 3641-3646
Regression of Chiari malformation type 2 following early postnatal meningomyelocele repair—a retrospective observation from an institutional series of patients
Purpose: Spontaneous regression of Chiari malformation type 2 (CM2) is observed rarely, as CM2 is associated with meningomyelocele (MMC) that is surgically repaired either pre- or early postnatally. While the radiological regression of CM2 occurs frequently following prenatal repair of MMC, it has been reported in only a few studies after postnatal repair. Methods: From the consecutive series of children with postnatally repaired MMC, we reviewed the clinical and radiological data regarding CM2, particularly its regression either spontaneously or following CSF diversion. Results: Eighteen children underwent postnatal repair of MMC between February 2011 and April 2023. CM2 was present in 16 (89%), and hydrocephalus in 15 children (83%), requiring shunting in 14 of them. During the mean clinical observation time (from birth to April 2023) of 59 ± 51 months, three children with CM2 (19%) underwent 1–2 foramen magnum decompressions (FMD), five children (28%) 1–4 surgical untethering procedures and 13 children with shunted hydrocephalus (93%) 1–5 shunt revisions. Out of sixteen children with CM2, we observed regression of CM2 on MRI in only one case (6%) during the mean radiological follow-up (from birth to the last MRI taken) of 49 ± 51 months. Conclusion: In our experience, spontaneous regression of CM2 in children with postnatally repaired MMC occurs quite rarely. Pathophysiological mechanisms behind the development of CM2 in children with MMC remain unclear, but our observation supports the hypothesis of an association between the downward displacement of the hindbrain and the low intraspinal pressure secondary to CSF leakage in children born with MMC.
- 29 August 2024
- Published by Springer Nature in Child's Nervous System
- Vol. 40 (11) , 3641-3646
Open AccessRegression of Chiari malformation type 2 following early postnatal meningomyelocele repair—a retrospective observation from an institutional series of patients
Purpose: Spontaneous regression of Chiari malformation type 2 (CM2) is observed rarely, as CM2 is associated with meningomyelocele (MMC) that is surgically repaired either pre- or early postnatally. While the radiological regression of CM2 occurs frequently following prenatal repair of MMC, it has been reported in only a few studies after postnatal repair. Methods: From the consecutive series of children with postnatally repaired MMC, we reviewed the clinical and radiological data regarding CM2, particularly its regression either spontaneously or following CSF diversion. Results: Eighteen children underwent postnatal repair of MMC between February 2011 and April 2023. CM2 was present in 16 (89%), and hydrocephalus in 15 children (83%), requiring shunting in 14 of them. During the mean clinical observation time (from birth to April 2023) of 59 ± 51 months, three children with CM2 (19%) underwent 1–2 foramen magnum decompressions (FMD), five children (28%) 1–4 surgical untethering procedures and 13 children with shunted hydrocephalus (93%) 1–5 shunt revisions. Out of sixteen children with CM2, we observed regression of CM2 on MRI in only one case (6%) during the mean radiological follow-up (from birth to the last MRI taken) of 49 ± 51 months. Conclusion: In our experience, spontaneous regression of CM2 in children with postnatally repaired MMC occurs quite rarely. Pathophysiological mechanisms behind the development of CM2 in children with MMC remain unclear, but our observation supports the hypothesis of an association between the downward displacement of the hindbrain and the low intraspinal pressure secondary to CSF leakage in children born with MMC.